Department of Infectious Diseases and Microbiology, Graduate School of Public Health, Pittsburgh, Pennsylvania, USA.
J Mol Diagn. 2010 Jan;12(1):102-8. doi: 10.2353/jmoldx.2010.090071. Epub 2009 Nov 30.
One-step, real-time PCR assays for rhinovirus have been developed for a limited number of PCR amplification platforms and chemistries, and some exhibit cross-reactivity with genetically similar enteroviruses. We developed a one-step, real-time PCR assay for rhinovirus by using a sequence detection system (Applied Biosystems; Foster City, CA). The primers were designed to amplify a 120-base target in the noncoding region of picornavirus RNA, and a TaqMan (Applied Biosystems) degenerate probe was designed for the specific detection of rhinovirus amplicons. The PCR assay had no cross-reactivity with a panel of 76 nontarget nucleic acids, which included RNAs from 43 enterovirus strains. Excellent lower limits of detection relative to viral culture were observed for the PCR assay by using 38 of 40 rhinovirus reference strains representing different serotypes, which could reproducibly detect rhinovirus serotype 2 in viral transport medium containing 10 to 10,000 TCID(50) (50% tissue culture infectious dose endpoint) units/ml of the virus. However, for rhinovirus serotypes 59 and 69, the PCR assay was less sensitive than culture. Testing of 48 clinical specimens from children with cold-like illnesses for rhinovirus by the PCR and culture assays yielded detection rates of 16.7% and 6.3%, respectively. For a batch of 10 specimens, the entire assay was completed in 4.5 hours. This real-time PCR assay enables detection of many rhinovirus serotypes with the Applied Biosystems reagent-instrument platform.
我们开发了一种一步实时 PCR 检测方法,用于检测鼻病毒,该方法适用于有限数量的 PCR 扩增平台和化学试剂,并且一些方法与遗传上相似的肠道病毒存在交叉反应。我们使用序列检测系统(Applied Biosystems;福斯特城,加利福尼亚州)开发了一种一步实时 PCR 检测方法,用于检测鼻病毒。该引物设计用于扩增小核糖核酸病毒 RNA 非编码区的 120 个碱基目标,并且设计了 TaqMan(Applied Biosystems)简并探针用于特异性检测鼻病毒扩增子。该 PCR 检测方法与包含 43 种肠道病毒株的 RNA 的 76 种非目标核酸无交叉反应性。通过使用 40 种鼻病毒参考株中的 38 种代表不同血清型的参考株,对该 PCR 检测方法进行了研究,结果显示其对病毒培养物的检测下限相对较低,该方法可以重复检测到病毒载量为 10 至 10,000 TCID50(50%组织培养感染剂量终点)/ml 的病毒的病毒运输培养基中鼻病毒血清型 2。然而,对于鼻病毒血清型 59 和 69,PCR 检测方法的灵敏度低于培养法。通过 PCR 和培养检测方法对 48 份来自感冒样疾病儿童的临床标本进行鼻病毒检测,其检测率分别为 16.7%和 6.3%。对于 10 份标本的一批检测,整个检测过程可在 4.5 小时内完成。该实时 PCR 检测方法可使用 Applied Biosystems 试剂-仪器平台检测多种鼻病毒血清型。